Assessing Leadership Styles on Pharmacovigilance Team Performance Outcomes

This study examines the influence of leadership styles on performance outcomes within pharmacovigilance teams operating in biopharmaceutical organizations.Specifically, transformational, transactional, and laissez-faire leadership styles are analyzed to determine their associations with key performance indicators (KPIs) such as adverse event reporting quality, response timeliness, regulatory compliance, and team job satisfaction.Employing a convergent mixed-methods design, quantitative data were collected via standardized surveys (n = 220 pharmacovigilance professionals) and archival performance records over a 12-month period.Qualitative insights were gleaned from semi-structured interviews with 20 team members and managers.Statistical analyses-including multiple regression and ANOVA-assessed the predictive strength of each leadership style on performance metrics, while thematic analysis of interview transcripts identified underlying mechanisms.Findings indicate that transformational leadership significantly predicts higher reporting accuracy ( = 0.42, p < .001),faster case processing times (F[2,217] = 8.37, p = .0004),and enhanced team satisfaction ( = 0.47, p < .001).Transactional leadership shows moderate positive effects on regulatory compliance rates ( = 0.28, p = .003)but negligible impact on innovation or discretionary effort.Laissez-faire leadership correlates with lower overall performance and increased error rates.This research underscores the critical role of transformational leadership behaviors-such as inspirational motivation and individualized consideration-in optimizing pharmacovigilance outcomes.Recommendations include targeted leadership development programs and organizational policy adjustments to foster transformational practices.